Celsion
+$0.06 (+6.07%) As of 3:37 PM UTC today
Why Robinhood?
You can buy or sell Celsion and other stocks, options, and ETFs commission-free!
About CLSN
Celsion Corporation Common Stock, also called Celsion, is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies.
CEO
Michael H. Tardugno
Employees
27
Headquarters
Lawrenceville, New Jersey
Founded
1982
CLSN Key Statistics
Market Cap
93.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.44M
High Today
$1.08
Low Today
$1.03
Open Price
$1.05
Volume
789.53K
52 Week High
$6.50
52 Week Low
$0.4305
CLSN Earnings
-$0.28
-$0.19
-$0.09
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
-$0.09 per share